BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Hematopoietic cell
,
Tamoxifen
,
rs7903146
,
SNCA
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
AR 1
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast SKBR3 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MDAMB231 cells treated with ligand perturbagens
L1000 CMAP - Breast cancer HS578T cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
The emerging neurological spectrum of AARS2-associated disorders.
AARS2 leukoencephalopathy: A new variant of mitochondrial encephalomyopathy.
Alanyl-tRNA Synthetase 2 (AARS2)-Related Ataxia Without Leukoencephalopathy.
Explained Variance and Intraclass Correlation in a Two-Level AR(1) Model.
A comparative simulation study of AR(1) estimators in short time series.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tra…
Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Freque…
Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Aceta…
A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ